top of page
Profile
Join date: May 22, 2025
Posts (338)
Jun 25, 2026 ∙ 2 min
Myelofibrosis: new strategies aim for more durable responses
Peter Löffelhardt speaks with Prof. Florian Heidel about the advances presented at EHA 2026, the future of combination therapies and the POIESIS clinical trial for people living with myelofibrosis.
11
0
Jun 23, 2026 ∙ 2 min
EHA 2026: new treatments and precision medicine open a promising chapter for MPN
Prof. Haifa Al-Ali joins Peter Löffelhardt to discuss some of the most relevant advances presented at EHA 2026 and the future of treatment in myeloproliferative neoplasms. Research and new treatments for essential thrombocythemia, polycythemia vera and myelofibrosis presented at EHA 2026. The field of myeloproliferative neoplasms (MPN) is experiencing a period of remarkable scientific activity. Research, clinical trials and therapeutic options for essential thrombocythemia, polycythemia vera...
37
0
Jun 21, 2026 ∙ 3 min
International Yoga Day: wellbeing is also part of the MPN journey
On International Yoga Day, we explore how yoga may support physical and emotional wellbeing in people living with MPN and how to join the Wellbeing Project.
15
0
bottom of page